| 19.0625 0.148 (0.78%) | 01-14 09:36 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.37 |
1-year : | 22.93 |
| Resists | First : | 19.16 |
Second : | 19.63 |
| Pivot price | 19.08 |
|||
| Supports | First : | 18.38 |
Second : | 15.29 |
| MAs | MA(5) : | 19.19 |
MA(20) : | 19.02 |
| MA(100) : | 18.32  |
MA(250) : | 17.06 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 61.2 |
D(3) : | 66.5 |
| RSI | RSI(14): 47.8 |
|||
| 52-week | High : | 19.69 | Low : | 13.77 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ HQH ] has closed above bottom band by 28.2%. Bollinger Bands are 43% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 19.33 - 19.45 | 19.45 - 19.54 |
| Low: | 18.49 - 18.64 | 18.64 - 18.75 |
| Close: | 18.71 - 18.93 | 18.93 - 19.09 |
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Mon, 12 Jan 2026
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - PR Newswire
Mon, 17 Nov 2025
HQH: Seeing Strong Recent Returns While Attractively Discounted - Seeking Alpha
Sun, 16 Nov 2025
abrdn Healthcare Investors Q3 2025 Commentary - Seeking Alpha
Tue, 11 Nov 2025
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - PR Newswire
Sat, 08 Nov 2025
HQH: Severely Underperforms Peers (Rating Downgrade) - Seeking Alpha
Fri, 07 Nov 2025
THQ: Outperforms Peers But Has Limited Growth Potential - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 52 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 91.09 |
| Profit Margin | 1 % |
| Operating Margin | 309 % |
| Return on Assets (ttm) | -88.2 % |
| Return on Equity (ttm) | -0.2 % |
| Qtrly Rev. Growth | 7.53e+006 % |
| Gross Profit (p.s.) | -67.64 |
| Sales Per Share | 12.72 |
| EBITDA (p.s.) | 1.04583e+007 |
| Qtrly Earnings Growth | 1.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0.2 |
| Price to Sales | 1.48 |
| Price to Cash Flow | 0.69 |
| Dividend | 0 |
| Forward Dividend | 45520 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|